This document provides a step by step guide on how to access the form to lift a suspension of a certification in the OGTR's Online Services Portal.
This document provides a step by step guide on how to access the form to surrender a certification in the OGTR's Online Services Portal.
In 2024, support for GM technologies largely reflects results shown in 2019. After the global COVID-19 pandemic and spikes in support in 2021, attitudes appear to have returned to a new ‘baseline’. 38% of the Australian community in support of its use in general.
This document outlines the three principles of regulator best practice performance by which the OGTR undertakes its regulatory functions.
Clinical trial of genetically modified influenza vaccine (H3N2 M2SR)
The determination of self-amplifying mRNA (sa-mRNA) as a GMO.
Clinical trial of GM vaccinia virus for the treatment of solid tumours
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2023-24.
This issue focusses on the IBC Forum and various consultations happening across the OGTR.
Commercial release of a genetically modified (GM) mosquito strain to help prevent dengue outbreaks